Abbott Laboratories

Former QuidelOrtho CEO Douglas Bryant Joins Board of Directors of Vital Biosciences

Retrieved on: 
Tuesday, April 9, 2024

Vital Biosciences today announced that Mr. Douglas Bryant has joined the company’s Board of Directors.

Key Points: 
  • Vital Biosciences today announced that Mr. Douglas Bryant has joined the company’s Board of Directors.
  • Vital Biosciences announced its work on a revolutionary new product, the VitalOne.
  • “Doug grew QuidelOrtho into a global leader in diagnostics, and a category defining company in point-of-care,” according to Vasu Nadella, CEO of Vital Biosciences.
  • He led the company during the acquisition of Ortho Clinical Diagnostics and subsequent renaming to QuidelOrtho in May 2022.

Sepsis Diagnostics Market Worth $890 million | MarketsandMarkets™.

Retrieved on: 
Monday, April 8, 2024

Key Market Players of Sepsis Diagnostics Industry:

Key Points: 
  • Key Market Players of Sepsis Diagnostics Industry:
    As of 2023, prominent players in sepsis diagnostics are bioMérieux (France), Becton Dickinson Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland).
  • Other players include T2 Biosystems (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), among others.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=92673155
    Sepsis Diagnostics Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

Sepsis Diagnostics Market Worth $890 million | MarketsandMarkets™.

Retrieved on: 
Monday, April 8, 2024

Key Market Players of Sepsis Diagnostics Industry:

Key Points: 
  • Key Market Players of Sepsis Diagnostics Industry:
    As of 2023, prominent players in sepsis diagnostics are bioMérieux (France), Becton Dickinson Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland).
  • Other players include T2 Biosystems (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), among others.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=92673155
    Sepsis Diagnostics Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

Orphan designation: Veliparib Treatment of ovarian cancer, 17/12/2010 Withdrawn

Retrieved on: 
Tuesday, April 9, 2024

Orphan designation: Veliparib Treatment of ovarian cancer, 17/12/2010 Withdrawn

Key Points: 


Orphan designation: Veliparib Treatment of ovarian cancer, 17/12/2010 Withdrawn

Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer

Retrieved on: 
Monday, March 25, 2024

Paris, France and Munich, Germany, March 25, 2024 – TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO).

Key Points: 
  • Paris, France and Munich, Germany, March 25, 2024 – TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO).
  • In conjunction with this, and following eight years at the helm of the business, Helmut Straubinger is retiring as President & CEO.
  • Ahmed Elmouelhi is a seasoned professional with more than 20 years of medical device experience across strategy, sales and marketing, R&D, and clinical science.
  • Before joining TRiCares, Ahmed served as the Senior Vice President of Product Marketing, Strategy, and Business Development at AtriCure.

Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt Benckiser Group PLC Following $60 Million Baby Formula Verdict and Subsequent Stock Plummet

Retrieved on: 
Friday, March 15, 2024

​LOS ANGELES, March 15, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTCMKTS: RBGLY) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Reckitt stock. Reckitt investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • ​LOS ANGELES, March 15, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTCMKTS: RBGLY) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Reckitt stock.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • Portnoy Law is initiating an investigation into Reckitt in light of recent events that have led to a significant decline in the company's stock value.
  • This follows an Illinois jury's decision to award $60 million in damages to the plaintiff in a lawsuit involving Reckitt's Enfamil baby formula.

Transverse Medical Appoints David C. Blowers to Board of Directors, Dr. Rahul Sharma as Independent Member, Carl St. Bernard rejoins Board.

Retrieved on: 
Tuesday, April 2, 2024

Transverse Medical is pleased to announce the appointment of David C. Blowers to the Board of Directors.

Key Points: 
  • Transverse Medical is pleased to announce the appointment of David C. Blowers to the Board of Directors.
  • Carl St. Bernard has been reinstated as an independent member to the Board of Directors; Mr. St. Bernard first joined the company in March of 2021 and has served as an Executive Advisor and Board Director.
  • Rahul P. Sharma, MD, has joined the Board of Directors as an independent member and will also Chair the Medical Advisory Board.
  • Mr. David C. Blowers is an experienced wealth management and finance professional, board director, C-Suite Executive, and currently serves as Vice Chairman of Northern Trust.

Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors

Retrieved on: 
Monday, April 1, 2024

GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.

Key Points: 
  • New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee
    GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors (the "Board"), effective immediately, expanding the Board to 14 members.
  • Ms. Turner brings significant global experience in both the animal health and broader healthcare industries.
  • Mr. Wallace is a well-respected animal health leader with more than 30 years of executive experience at companies such as Fort Dodge Animal Health, Trupanion and Ceva.
  • "We are pleased to welcome Kathy and Craig, both accomplished animal health industry executives, to the Elanco Board," said Jeff Simmons, President and CEO of Elanco Animal Health.

Laboratory Information Management System (LIMS) Market Size to Grow by USD 907.08 million from 2023 to 2027, Market growth at 9.08% CAGR expected during the forecast period, Technavio

Retrieved on: 
Tuesday, March 26, 2024

By geography, the global laboratory information management system (lims) market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Key Points: 
  • By geography, the global laboratory information management system (lims) market is segmented into North America, Europe, Asia, and Rest of World (ROW).
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global laboratory information management system (lims) market.
  • Driving Forces in the LIMS Market:
    Stringent compliance and governmental regulations propel the growth of the Laboratory Management System (LIMS) market.
  • Growth of the Laboratory Information Management System (LIMS) Market industry across North America, Europe, Asia, and Rest of World (ROW)
    Gain instant access to 17,000+ market research reports.

The Wolfe Companies, LLC Welcomes New Chief Technology Officer to the Executive Leadership Team to Drive Innovation and Growth

Retrieved on: 
Wednesday, March 20, 2024

PITTSBURGH, March 20, 2024 /PRNewswire-PRWeb/ -- The Wolfe Companies, LLC, (http://www.wolfe.com/), the parent company of GiftYa, Gift Card Granny, PerfectGift.com, Give InKind, and Reaf Marketing proudly welcomes Glenn Morten as its new Chief Technology Officer (CTO). As CTO, Glenn will play a crucial role in steering the growth of the company as it embarks on more enterprise-level initiatives.

Key Points: 
  • The Wolfe Companies, LLC, the parent company of GiftYa, Gift Card Granny, PerfectGift.com, Give InKind, and Reaf Marketing proudly welcomes Glenn Morten as its new Chief Technology Officer (CTO).
  • PITTSBURGH, March 20, 2024 /PRNewswire-PRWeb/ -- The Wolfe Companies, LLC, ( http://www.wolfe.com/ ), the parent company of GiftYa, Gift Card Granny, PerfectGift.com, Give InKind, and Reaf Marketing proudly welcomes Glenn Morten as its new Chief Technology Officer (CTO).
  • "We are thrilled to welcome Glenn to our executive team," says Jason S. Wolfe, Founder and Chief Executive Officer of The Wolfe Companies, LLC.
  • With a background spanning diverse domains including defense, medical technology, internet, entertainment, artificial intelligence, and cybersecurity, Glenn is well-equipped to drive innovation at Wolfe.